Molecular background and physiological consequences of altered peripheral serotonin homeostasis in adult rats perinatally treated with tranylcypromine

Journal of Physiology and Pharmacology

Volumn 66, Issue 4, 2015, Pages 529-537

  Blazevic, S ^a   Erjavec, I ^b   Brizic, M ^a   Vukicevic, S ^b   Hranilovic, Dubravka ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Bone remodeling; Hematopoiesis; Monoamine oxidase; Platelets; Serotonin; Tryptophan hydroxylase

Indexed keywords

MESSENGER RNA; SEROTONIN; TRANYLCYPROMINE; AMINE OXIDASE (FLAVIN CONTAINING); MONOAMINE OXIDASE INHIBITOR; TPH1 PROTEIN, RAT; TRYPTOPHAN HYDROXYLASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD ANALYSIS; BONE REMODELING; CONTROLLED STUDY; HEMATOPOIESIS; HOMEOSTASIS; METABOLIC REGULATION; MOLECULAR BIOLOGY; NONHUMAN; QUANTITATIVE ANALYSIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; BLOOD CELL COUNT; BONE; DRUG EFFECTS; ENZYMOLOGY; FEMALE; GENETICS; MALE; METABOLISM; NEWBORN; PERIPHERAL NERVOUS SYSTEM; PREGNANCY; SEXUAL DEVELOPMENT; THROMBOCYTE; WISTAR RAT;

ANIMALS; ANIMALS, NEWBORN; BLOOD CELL COUNT; BLOOD PLATELETS; BONE AND BONES; BONE REMODELING; FEMALE; HOMEOSTASIS; MALE; MONOAMINE OXIDASE; MONOAMINE OXIDASE INHIBITORS; PERIPHERAL NERVOUS SYSTEM; PREGNANCY; RATS; RATS, WISTAR; SEROTONIN; SEX CHARACTERISTICS; TRANYLCYPROMINE; TRYPTOPHAN HYDROXYLASE;

EID: 84940741481     PISSN: 08675910     EISSN: 18991505     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Walther DJ, Bader M. A unique central tryptophan hydroxylase isoform. Biochem Pharmacol 2003; 66: 1673-1680.
2. Billett E. Monoamine Oxidase (MAO) in human peripheral tissues. Neurotoxicology2004; 25: 139-148.
3. Whitaker-Azmitia PM. Serotonin and brain development: role in human developmental diseases. Brain Res Bull 2001; 56: 479-485.
4. Lesch KP, Waider J. Serotonin in the modulation of neural plasticity and networks: implications for neurodevelopmental disorders. Neuron 2012; 76: 175-191.
5. Palus K, Chrobok L, Lewandowski MH. Depolarization of the intergeniculate leaflet neurons by serotonin - in vitro study. J Physiol Pharmacol 2013; 64: 773-778.
6. Racke K, Reimann A, Schworer H, Kilbinger H. Regulation of 5-HT release from enterochromaffin cells. Behav Brain Res 1996; 73: 83-87.
7. Berger M, Gray JA, Roth BL. The expanded biology of serotonin. Annu Rev Med 2009; 60: 355-366.
8. Amireault P, Sibon D, Cote F. Life without peripheral serotonin: insights from tryptophan hydroxylase 1 knockout mice reveal the existence of paracrine/autocrine serotonergic networks. ACS Chem Neurosci 2013; 4: 64-71.
9. Ducy P, Karsenty G. The two faces of serotonin in bone biology. J Cell Biol 2010; 191: 7-13.
10. De Vernejoul MC, Collet C, Chabbi-Achengli Y. Serotonin: good or bad for bone. BoneKEy Rep2012; 1: 120.
11. Modder UI, Achenbach SJ, Amin S, Riggs BL, Melton LJ, Khosla S. Relation of serum serotonin levels to bone density and structural parameters in women. J Bone Miner Res 2010; 25: 415-422.
12. Haney EM, Chan BK, Diem SJ, et al. Association of low bone mineral density with selective serotonin reuptake inhibitor use by older men. Arch Intern Med 2007; 167: 1246-1251.
13. Mezuk B, Eaton WW, Golden SH, Wand G, Lee HB. Depression, antidepressants, and bone mineral density in a population-based cohort. J Gerontol A Biol Sci Med Sci 2008; 63: 1410-1415.
14. Seifert CF, Wiltrout TR. Calcaneal bone mineral density in young adults prescribed selective serotonin reuptake inhibitors. Clin Ther 2013; 35: 1412-1417.
15. Yadav VK, Ryu JH, Suda N, et al. Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum. Cell 2008; 135: 825-837.
16. Chabbi-Achengli Y, Coudert AE, Callebert J, et al. Decreased osteoclastogenesis in serotonin-deficient mice. Proc Natl Acad Sci USA 2012; 109: 2567-2572.
17. Yadav VK, Oury F, Suda N, et al. Leptin regulation of bone mass, appetite and energy expenditure relies on its ability to inhibit serotonin synthesis in the brainstem. Cell 2009; 138: 976-989.
18. Arai F, Hirao A, Suda T. Regulation of hematopoiesis and its interaction with stem cell niches. Int J Hematol 2005; 82: 371-376.
19. Ding L, Morrison SJ. Haematopoietic stem cells and early lymphoid progenitors occupy distinct bone marrow niches. Nature 2013; 495: 231-235.
20. Kalinkovich A, Spiegel A, Shivtiel S, et al. Blood-forming stem cells are nervous: direct and indirect regulation of immature human CD34+ cells by the nervous system. Brain Behav Immun 2009; 23: 1059-1065.
21. Dygai A, Skurikhin EG. Monoaminergic regulation of hemopoiesis under extreme conditions. Bull Exp Biol Med 2011; 151: 171-178.
22. Burkhardt R, Kettner G, Bohm W, et al. Changes in trabecular bone, hematopoiesis and bone marrow vessels in aplastic anemia, primary osteoporosis, and old age: a comparative histomorphometric study. Bone 1987; 164: 157-164.
23. Calvi LM, Adams GB, Weibrecht KW, et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 2003; 425: 841-846.
24. Zhang J, Niu C, Ye L, et al. Identification of the haematopoietic stem cell niche and control of the niche size. Nature 2003; 425: 836-841.
25. Pereira A, McLaren A, Bell WR, Copolov D, Dean B. Potential clozapine target sites on peripheral hematopoietic cells and stromal cells of the bone marrow. Pharmacogenomics J 2003; 3: 227-234.
26. Yang M, Li K, Ng PC, et al. Promoting effects of serotonin on hematopoiesis: ex vivo expansion of cord blood CD34+ stem/progenitor cells, proliferation of bone marrow stromal cells, and antiapoptosis. Stem Cells 2007; 25: 1800-1806.
27. Borawski J, Mazerska M, Pawlak K, Mysliwiec M. Ketanserin lowers erythropoietin concentration in hemodialyzed patients treated with the hormone. J Cardiovasc Pharmacol 1995; 26: 621-626.
28. Yang M, Srikiatkhachorn A, Anthony M, Chong BH. Serotonin stimulates megakaryocytopoiesis via the 5-HT2 receptor. Blood Coagul Fibrinolysis 1996; 7: 127-133.
29. Amireault P, Hatia S, Bayard E, et al. Ineffective erythropoiesis with reduced red blood cell survival in serotonin-deficient mice. Proc Natl Acad Sci USA 2011; 108: 13141-13146.
30. Slauson DO, Walker C, Kristensen F, Wang Y, de Weck AL. Mechanisms of serotonin-induced lymphocyte proliferation inhibition. Cell Immunol 1984; 84: 240-252.
31. Connor TJ, Kelly JP, Leonard BE. An assessment of the acute effects of the serotonin releasers methylenedi-oxymethamphetamine, methylenedioxyamphetamine and fenfluramine on immunity in rats. Immunopharmacology 2000; 46: 223-235.
32. Hranilovic D, Blazevic S, Ivica N, Cicin-Sain L, Oreskovic D. The effects of the perinatal treatment with 5-hydroxytryptophan or tranylcypromine on the peripheral and central serotonin homeostasis in adult rats. Neurochem Int 2011; 59: 202-207.
33. Blazevic S, Colic L, Culig L, Hranilovic D. Anxiety-like behavior and cognitive flexibility in adult rats perinatally exposed to increased serotonin concentrations. Behav Brain Res 2012; 230: 175-181.
34. Blazevic S, Hranilovic D. Expression of 5HT-related genes after perinatal treatment with 5HT agonists. Transl Neurosci 2013; 4: 165-171.
35. Blazevic S, Jurcic Z, Hranilovic D. Perinatal treatment of rats with MAO inhibitor tranylcypromine. Transl Neurosci. 2010; 1: 49-54.
36. Lauder JM, Liu J, Grayson DR. In utero exposure to serotonergic drugs alters neonatal expression of 5-HT(1A) receptor transcripts: a quantitative RT-PCR study. Int J Dev Neurosci 2000; 18: 171-176.
37. Kelly PA, Ritchie IM, Quate L, McBean DE, Olverman HJ. Functional consequences of perinatal exposure to 3,4-methylenedioxymethamphetamine in rat brain. Br J Pharmacol 2002; 137: 963-970.
38. Henderson MG, McMillen BA. Changes in dopamine, serotonin and their metabolites in discrete brain areas of rat offspring after in utero exposure to cocaine or related drugs. Teratology 2005; 48: 421-430.
39. Frederick AL, Stanwood GD. Drugs, biogenic amine targets and the developing brain. Dev Neurosci 2009; 31: 7-22.
40. Pawluski JL. Perinatal selective serotonin reuptake inhibitor exposure: impact on brain development and neural plasticity. Neuroendocrinology 2012; 95: 39-46.
41. Myohanen TT, Schendzielorz N, Mannisto PT. Distribution of catechol-O-methyltransferase (COMT) proteins and enzymatic activities in wild-type and soluble COMT deficient mice. J Neurochem 2010; 113: 1632-1643.
42. Chen K, Holschneider DP, Wu W, Rebrini I, Shih JC. A spontaneous point mutation produces monoamine oxidase A/B knock-out mice with greatly elevated monoamines and anxiety-like behavior. J Biol Chem 2004; 279: 39645-39652.
43. Westbroek I, van der Plas a, de Rooij KE, Klein-Nulend J, Nijweide PJ. Expression of serotonin receptors in bone. J Biol Chem 2001; 276: 28961-28968.
44. Gustafsson BI, Thommesen L, Stunes AK, et al. Serotonin and fluoxetine modulate bone cell function in vitro. J Cell Biochem 2006; 98: 139-151.
45. Collet C, Schiltz C, Geoffroy V, Maroteaux L, Launay JM, de Vernejoul MC. The serotonin 5-HT2B receptor controls bone mass via osteoblast recruitment and proliferation. FASEB J 2008; 22: 418-427.
46. Dai SQ, Yu LP, Shi X, et al. Serotonin regulates osteoblast proliferation and function in vitro. Braz J Med Biol Res 2014; 47: 759-765.
47. Gustafsson BI, Westbroek I, Waarsing JH, et al. Long-term serotonin administration leads to higher bone mineral density, affects bone architecture, and leads to higher femoral bone stiffness in rats. J Cell Biochem 2006; 97: 1283-1291.
48. Warden SJ, Robling AG, Sanders MS, Bliziotes MM, Turner CH. Inhibition of the serotonin (5-hydroxytryptamine) transporter reduces bone accrual during growth. Endocrinology 2005; 146: 685-693.
49. Yadav VK, Balaji S, Suresh PS, et al. Pharmacological inhibition of gut-derived serotonin synthesis is a potential bone anabolic treatment for osteoporosis. Nat Med 2010; 16: 308-312.
50. Elefteriou F. Regulation of bone remodeling by the central and peripheral nervous system. Arch Biochem Biophys 2008; 473: 231-236.
51. Samir SM, Malek HA. Effect of cannabinoid receptors 1 modulation on osteoporosis. J Physiol Pharmacol 2014; 65: 687-694.
52. Duerschmied D, Suidan GL, Demers M, et al. Platelet serotonin promotes the recruitment of neutrophils to sites of acute inflammation in mice. Blood 2013; 121: 1008-1015.
53. Schepers K, Hsiao EC, Garg T, Scott MJ, Passegue E. Activated Gs signaling in osteoblastic cells alters the hematopoietic stem cell niche in mice. Blood 2012; 120: 3425-3435.